Other commercial insurers (UnitedHealthcare, Aetna, etc.): Many large employers are reducing or excluding obesity drug coverage due to cost
Recent data from LLY on Retatrutide (as well as other promising solutions presented at the American Diabetes Association conference) have made me consider something that seems inevitable on the surface, but the timeline of which may be greatly accelerated: obesity may have a cure (specifically - diabesity, the word for diabetes and obesity as comorbidities) in these new medications
[1] Slow Wave Sleep (SWS), often referred to as deep sleep, is considered a pivotal phase within the overall sleep architecture, which is composed of non-rapid eye movement (NREM) sleep and rapid eye movement (REM) sleep
When combined with antihypertensive drugs such as amlodipine, atenolol, or losartan, it can cause blood pressure to drop lower than intended, leading to dizziness, lightheadedness, or fainting
Reduction of DHT: GHK-Cu, when combined with other peptides, can inhibit 5-alpha-reductase, the enzyme that converts testosterone into DHTa key contributor to male pattern baldness
I love this product for multiple reasons
